Study of liver health in primary biliary cholangitis
Part of Digestive system clinical trials.
This study looks at the characteristics and progression of primary biliary cholangitis (PBC), a chronic liver disease. It aims to find factors that may lead to worsening of the disease, which could help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of primary biliary cholangitis (PBC), a liver disease that affects the bile ducts.
- You must have had a liver biopsy, which is a procedure where a small sample of liver tissue is taken for testing.
- You must not have other liver diseases, such as hepatitis B or C, alcoholic liver disease, fatty liver disease, or autoimmune hepatitis.
- You must not have liver cancer.
- You must be 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with primary biliary cholangitis (a long-term liver and bile duct condition). It may help doctors better understand the disease in different people, including those identified by specific blood antibody tests.
This study tracks patients with primary biliary cholangitis (PBC) over time to understand long-term outcomes. It aims to gather information that could improve care and management for people with PBC.
This trial looks at whether slowly reducing UDCA (a medication for primary biliary cholangitis) is safe and still helpful in people whose liver tests have improved. It may help some patients avoid higher doses if their disease is well controlled.
This research study tracks how well Primary Biliary Cholangitis (PBC) responds to standard medication (UDCA) and what happens to patients' health over time. It may help doctors understand which treatments work best for different people.
This is a registry study that collects health information from people with primary biliary cholangitis (PBC), a rare liver disease where the immune system damages bile ducts. By joining, you help researchers better understand PBC and improve care for patients with this condition.
This study collects and stores samples from people with PSC (primary sclerosing cholangitis), PBC (primary biliary cholangitis), and some related liver conditions. Researchers use these samples to better understand these diseases and support future research.
Hear when a new PBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.